Murray Stahl’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.57M | Sell |
44,552
-154
| -0.3% | -$8.84K | 0.03% | 105 |
|
|
2026
Q1 | $2.71M | Sell |
44,706
-404
| -0.9% | -$23.6K | 0.03% | 99 |
|
|
2025
Q4 | $2.43M | Buy |
45,110
+197
| +0.4% | +$9.48K | 0.03% | 100 |
|
|
2025
Q3 | $2.03M | Sell |
44,913
-16,404
| -27% | -$766K | 0.02% | 116 |
|
|
2025
Q2 | $2.84M | Buy |
61,317
+1,504
| +3% | +$73.8K | 0.03% | 103 |
|
|
2025
Q1 | $3.65M | Sell |
59,813
-663
| -1% | -$38.6K | 0.04% | 83 |
|
|
2024
Q4 | $3.42M | Buy |
60,476
+1,094
| +2% | +$61.1K | 0.04% | 89 |
|
|
2024
Q3 | $3.07M | Buy |
59,382
+14,364
| +32% | +$674K | 0.05% | 96 |
|
|
2024
Q2 | $1.87M | Buy |
45,018
+1,530
| +4% | +$68.5K | 0.03% | 112 |
|
|
2024
Q1 | $2.36M | Buy |
43,488
+952
| +2% | +$48.5K | 0.04% | 91 |
|
|
2023
Q4 | $2.18M | Buy |
42,536
+155
| +0.4% | +$8.14K | 0.05% | 91 |
|
|
2023
Q3 | $2.46M | Sell |
42,381
-150
| -0.4% | -$9.19K | 0.05% | 85 |
|
|
2023
Q2 | $2.72M | Hold |
42,531
| – | – | 0.06% | 86 |
|
|
2023
Q1 | $2.95M | Sell |
42,531
-4,937
| -10% | -$348K | 0.06% | 76 |
|
|
2022
Q4 | $3.42M | Sell |
47,468
-333
| -0.7% | -$25.1K | 0.06% | 73 |
|
|
2022
Q3 | $3.4M | Buy |
47,801
+220
| +0.5% | +$16K | 0.07% | 69 |
|
|
2022
Q2 | $3.66M | Sell |
47,581
-283
| -0.6% | -$21.6K | 0.08% | 70 |
|
|
2022
Q1 | $3.5M | Sell |
47,864
-120
| -0.3% | -$8.06K | 0.07% | 84 |
|
|
2021
Q4 | $2.99M | Buy |
47,984
+975
| +2% | +$57.2K | 0.07% | 95 |
|
|
2021
Q3 | $2.78M | Sell |
47,009
-700
| -1% | -$46.1K | 0.07% | 98 |
|
|
2021
Q2 | $3.19M | Sell |
47,709
-12
| -0% | -$782 | 0.06% | 95 |
|
|
2021
Q1 | $3.01M | Sell |
47,721
-20
| -0% | -$1.24K | 0.07% | 90 |
|
|
2020
Q4 | $2.96M | Sell |
47,741
-3,133
| -6% | -$193K | 0.1% | 86 |
|
|
2020
Q3 | $3.07M | Sell |
50,874
-160
| -0.3% | -$9.63K | 0.12% | 78 |
|
|
2020
Q2 | $3M | Sell |
51,034
-1,888
| -4% | -$113K | 0.11% | 78 |
|
|
2020
Q1 | $2.95M | Sell |
52,922
-2,396
| -4% | -$146K | 0.13% | 72 |
|
|
2019
Q4 | $3.55M | Buy |
55,318
+7,000
| +14% | +$401K | 0.1% | 69 |
|
|
2019
Q3 | $2.45M | Sell |
48,318
-85
| -0.2% | -$4K | 0.07% | 92 |
|
|
2019
Q2 | $2.19M | Buy |
48,403
+1,615
| +3% | +$75.2K | 0.06% | 109 |
|
|
2019
Q1 | $2.23M | Buy |
+46,788
| New | +$2.33M | 0.06% | 111 |
|
Other funds holding BMY
Murray Stahl's BMY Position: Q2 2026 in Review
Murray Stahl reduced its Bristol-Myers Squibb (BMY) stake by 0.34% in Q2 2026, selling an estimated $8.84K and leaving 44,552 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #105.
Murray Stahl first reported a position in BMY in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.66M in Q2 2022. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Murray Stahl held 44,552 shares of Bristol-Myers Squibb worth $2.57M as of Q2 2026.
- Murray Stahl sold 154 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.84K.
- Bristol-Myers Squibb made up 0.03% of Murray Stahl's portfolio in Q2 2026, its #105 holding.
- Murray Stahl first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 30 quarters since.
- Murray Stahl's Bristol-Myers Squibb position peaked at $3.66M in Q2 2022.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.